Cognitive Processing Therapy + Memory Support for PTSD
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that any psychiatric medication dose be stable for the past four weeks before participating.
What data supports the effectiveness of the treatment Cognitive Processing Therapy + Memory Support for PTSD?
Cognitive Processing Therapy (CPT) is a well-researched treatment that has been shown to effectively reduce PTSD symptoms in various groups, including combat veterans and sexual assault survivors. Studies have demonstrated significant improvements in PTSD and depression symptoms, with benefits maintained over time. Additionally, CPT has been adapted to address co-occurring issues like alcohol dependence, showing promise in improving both PTSD and related problems.12345
Is Cognitive Processing Therapy (CPT) safe for humans?
How is Cognitive Processing Therapy (CPT) unique in treating PTSD?
Cognitive Processing Therapy (CPT) is unique because it focuses on changing the way individuals process traumatic events by addressing their thoughts and beliefs, which can lead to behavioral changes and symptom improvement. It is particularly effective for PTSD and can be adapted for group or individual settings, and even modified to address co-occurring issues like heavy alcohol use.12349
What is the purpose of this trial?
The efficacy of psychological interventions for posttraumatic stress disorder (PTSD) is likely limited by the difficulty participants have learning and remembering important therapy content. Accordingly, the present study will examine the utility of integrating a Memory Support (MS) intervention into Cognitive Processing Therapy (CPT), an empirically supported and widely disseminated treatment for PTSD. MS was designed to integrate techniques aimed at facilitating encoding, consolidation, and retrieval of new learning into existing treatments, and has been shown to improve outcomes when integrated into cognitive therapy for depression. A pilot randomized controlled trial (n=52) comparing CPT with Memory Support (CPT+MS) to CPT-alone will be conducted. Study participants will be adults diagnosed with PTSD.The primary aim of the trial will be to determine if CPT+MS will lead to greater memory and learning of therapy content relative to CPT-alone, and to establish the acceptability and feasibility of integrating MS into CPT. Secondary aims include a preliminary examination of treatment efficacy, as indicated by the magnitude of changes in PTSD symptoms between conditions, and target validation, as indicated by associations between memory and learning of therapy content and treatment response. Exploratory analyses will examine several indicators of baseline memory-related cognitive functioning as predictors of memory and learning of therapy content, providing preliminary data to inform future research on personalized application of MS. Results of the trial will advance scientific knowledge about methods for optimizing memory and learning as a mechanism for improving PTSD treatment outcomes.
Research Team
Joseph Carpenter, PhD MA
Principal Investigator
VA Boston Healthcare System, BUSM Psychiatry Dept.
Eligibility Criteria
Adults with PTSD can join this study. They must have a stable dose of psychiatric meds for the last month if they're taking any, and veterans are specifically welcomed. People with unstable bipolar disorder, psychosis, severe substance abuse, or past severe brain injury cannot participate. Also excluded are those with high verbal memory skills or significant cognitive impairment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Processing Therapy (CPT) with or without Memory Support (MS) for PTSD
Mid-treatment
Assessment of memory of therapy content and client satisfaction
Post-treatment
Evaluation of changes in PTSD symptoms, depression, and cognitive functioning
Follow-up
Participants are monitored for long-term changes in PTSD symptoms and memory of therapy content
Treatment Details
Interventions
- Cognitive Processing Therapy (CPT)
- Memory Support (MS)
Cognitive Processing Therapy (CPT) is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
VA Boston Healthcare System
Collaborator